Linked Data API

Show Search Form

Search Results

1110551
star this property registered interest true more like this
star this property date less than 2019-04-09more like thismore than 2019-04-09
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps is the Government taking to ensure timely access to maintenance medication for people with cancer. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 242692 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2019-04-15more like thismore than 2019-04-15
star this property answer text <p>The Department fully understands that maintaining access to cancer medication is vitally important to many people in this country.</p><p> </p><p>There is already a team within the Department that deals with medicine supply issues arising both in the community and hospitals. We have well established procedures to deal with medicine shortages, from whatever cause, and work closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England and others operating in the supply chain to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p> </p><p>If we are aware of issues with cancer medications we work with national clinical experts to advise on management plans and ensure that appropriate information is provided to the National Health Service and specialist patient groups.</p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-04-15T12:58:08.703Zmore like thismore than 2019-04-15T12:58:08.703Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1110552
star this property registered interest true more like this
star this property date less than 2019-04-09more like thismore than 2019-04-09
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medical Treatments more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the appraisal process for personalised treatments for small patient groups. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 242693 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2019-04-15more like thismore than 2019-04-15
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care. Through its technology appraisal and highly specialised technologies programmes, NICE plays an important role in ensuring that patients are able to benefit from effective new treatments, including treatments for small numbers of patients. NICE has recommended a number of drugs for small patient populations through these programmes that are now routinely funded by the National Health Service for eligible patients.</p><p> </p><p>NICE periodically reviews its methods and processes to ensure that they keep pace with developments in science and healthcare. NICE will be carrying out a review of its technology appraisal and highly specialised technologies methods in 2019/20.</p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-04-15T12:55:57.447Zmore like thismore than 2019-04-15T12:55:57.447Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1121970
star this property registered interest true more like this
star this property date less than 2019-04-18more like thismore than 2019-04-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 April 2019 to Question 242692 on Cancer: Drugs, what steps the Government is taking to give timely NICE and NHS approval to enable access to maintenance medication for people with cancer. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 245610 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2019-04-25more like thismore than 2019-04-25
star this property answer text <p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources. NHS England is legally required to fund cancer drugs recommended in NICE technology appraisal guidance.</p><p>The Government wants patients with cancer to be able to benefit from rapid access to effective new drugs, including for maintenance treatment. Under arrangements introduced in 2016, NICE now develops technology appraisal guidance for the NHS on all new cancer drugs. Wherever possible, NICE aims to issue draft guidance on new cancer drugs before licensing and to publish final guidance within 90 days of licensing.</p><p>Funding is available through the Cancer Drugs Fund from the point at which NICE draft recommendations are published, or if the drug is not currently licensed, from the point of licensing. This ensures patients are able to benefit from effective new cancer drugs as quickly as possible.</p>
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-04-25T14:05:35.397Zmore like thismore than 2019-04-25T14:05:35.397Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1124146
star this property registered interest true more like this
star this property date less than 2019-05-01more like thismore than 2019-05-01
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 April 2019 to Question 245610, how many forms of cancer have no maintenance drug available at any stage in the treatment plan. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 249828 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2019-05-08more like thismore than 2019-05-08
star this property answer text <p>The information requested is not available.</p> more like this
unstar this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-05-08T13:54:02.043Zmore like thismore than 2019-05-08T13:54:02.043Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1172080
star this property registered interest true more like this
star this property date less than 2020-01-20more like thismore than 2020-01-20
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the proposed Innovative Medicines Fund does not adversely affect funding available for cancer drugs. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 5324 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2020-01-23more like thismore than 2020-01-23
star this property answer text <p>The Cancer Drugs Fund will be extended to create a new Innovative Medicines Fund so that doctors can use the most advanced, life-saving treatments for conditions such as autoimmune disease or cancer, or for children with other rare diseases.</p><p>Detailed proposals for the new Innovative Medicines Fund are in development and will be consulted on in due course. The will extend the successes of the reformed Cancer Drugs Fund into other areas.</p><p> </p><p> </p><p> </p> more like this
unstar this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 5325 more like this
star this property question first answered
less than 2020-01-23T12:16:26.137Zmore like thismore than 2020-01-23T12:16:26.137Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1172081
star this property registered interest true more like this
star this property date less than 2020-01-20more like thismore than 2020-01-20
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer Drugs Fund more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans he has to consult on his proposed reforms to the Cancer Drugs Fund. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 5325 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2020-01-23more like thismore than 2020-01-23
star this property answer text <p>The Cancer Drugs Fund will be extended to create a new Innovative Medicines Fund so that doctors can use the most advanced, life-saving treatments for conditions such as autoimmune disease or cancer, or for children with other rare diseases.</p><p>Detailed proposals for the new Innovative Medicines Fund are in development and will be consulted on in due course. The will extend the successes of the reformed Cancer Drugs Fund into other areas.</p><p> </p><p> </p><p> </p> more like this
unstar this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 5324 more like this
star this property question first answered
less than 2020-01-23T12:16:26.187Zmore like thismore than 2020-01-23T12:16:26.187Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1175547
star this property registered interest true more like this
star this property date less than 2020-02-03more like thismore than 2020-02-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading National Institute for Health and Care Excellence more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, which patient organisations are members of the (a) modifiers considered in decision-making, (b) exploring uncertainty, (c) types of evidence, (d) health-related quality of life, (e) technology specific issues, (f) discounting, (g) cost-minimisation methods (h) costs used in HTA, (i) equality considerations in guideline development, (j) general approach to decision-making and (k) position of technologies in care pathway, NICE methods review task and finish groups. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 11443 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2020-02-06more like thismore than 2020-02-06
star this property answer text <p>The following patient groups are currently involved across the programme of task and finish groups. The National Institute for Health and Care Excellence (NICE) has advised that it continues to seek further members for the task and finish groups, and a full list of members is still to be finalised.</p><p>- Alzheimer's Research UK;</p><p>- Breast Cancer Now;</p><p>- Cancer52;</p><p>- Cystic Fibrosis Trust ;</p><p>- Diabetes UK;</p><p>- Genetic Alliance UK;</p><p>- Leukaemia CARE;</p><p>- Multiple Sclerosis Society;</p><p>- Muscular Dystrophy UK;</p><p>- Myeloma UK;</p><p>- Neuroendocrine Cancer UK;</p><p>- Prostate cancer UK; and</p><p>- Sarcoma UK.</p><p> </p><p>In recruiting patient organisations to the NICE methods review task and finish groups, patients on the methods working group were asked to nominate representatives with a range of experience. Additional representatives were nominated by NICE where particular expertise or input was required. The organisations involved in the task and finish groups cover a broad spectrum of disease areas including cancer, non-cancer and rare diseases.<strong> </strong></p>
unstar this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 11444 more like this
star this property question first answered
less than 2020-02-06T17:20:14.56Zmore like thismore than 2020-02-06T17:20:14.56Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1175548
star this property registered interest true more like this
star this property date less than 2020-02-03more like thismore than 2020-02-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading National Institute for Health and Care Excellence more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how patient organisations were recruited to the 11 NICE methods review task and finish groups. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 11444 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2020-02-06more like thismore than 2020-02-06
star this property answer text <p>The following patient groups are currently involved across the programme of task and finish groups. The National Institute for Health and Care Excellence (NICE) has advised that it continues to seek further members for the task and finish groups, and a full list of members is still to be finalised.</p><p>- Alzheimer's Research UK;</p><p>- Breast Cancer Now;</p><p>- Cancer52;</p><p>- Cystic Fibrosis Trust ;</p><p>- Diabetes UK;</p><p>- Genetic Alliance UK;</p><p>- Leukaemia CARE;</p><p>- Multiple Sclerosis Society;</p><p>- Muscular Dystrophy UK;</p><p>- Myeloma UK;</p><p>- Neuroendocrine Cancer UK;</p><p>- Prostate cancer UK; and</p><p>- Sarcoma UK.</p><p> </p><p>In recruiting patient organisations to the NICE methods review task and finish groups, patients on the methods working group were asked to nominate representatives with a range of experience. Additional representatives were nominated by NICE where particular expertise or input was required. The organisations involved in the task and finish groups cover a broad spectrum of disease areas including cancer, non-cancer and rare diseases.<strong> </strong></p>
unstar this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 11443 more like this
star this property question first answered
less than 2020-02-06T17:20:14.623Zmore like thismore than 2020-02-06T17:20:14.623Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1175549
star this property registered interest true more like this
star this property date less than 2020-02-03more like thismore than 2020-02-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading National Institute for Health and Care Excellence more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps the NICE methods review task and finish groups will take to consult with the wider health charity sector. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 11445 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2020-02-06more like thismore than 2020-02-06
star this property answer text <p>The National Institute for Heath and Care Excellence (NICE) has advised that a six week public consultation on the proposals for changing its methods and processes will take place this summer. We understand that further work on the timetable is in progress and will be communicated in due course.</p><p>The wider health charity sector will have an opportunity to review the proposals for change from the task and finish groups during this consultation.</p><p>NICE also held a webinar with stakeholders in November 2019 to share how and why health technology evaluation is changing and what it means for patients. The webinar is available on the NICE website at the following link:</p><p><a href="https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation" target="_blank">https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation</a></p><p>NICE staff have also participated in a number of events to engage with the patient community, including the charity sector and about the methods review.</p><p><strong> </strong></p>
unstar this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 11446 more like this
star this property question first answered
less than 2020-02-06T17:21:30.47Zmore like thismore than 2020-02-06T17:21:30.47Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this
1175550
star this property registered interest true more like this
star this property date less than 2020-02-03more like thismore than 2020-02-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading National Institute for Health and Care Excellence more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the full consultation on the proposed reforms to NICE methods and processes. more like this
star this property tabling member constituency Sheffield South East remove filter
star this property tabling member printed
Mr Clive Betts more like this
star this property uin 11446 more like this
star this property answer
answer
unstar this property is ministerial correction false remove filter
star this property date of answer less than 2020-02-06more like thismore than 2020-02-06
star this property answer text <p>The National Institute for Heath and Care Excellence (NICE) has advised that a six week public consultation on the proposals for changing its methods and processes will take place this summer. We understand that further work on the timetable is in progress and will be communicated in due course.</p><p>The wider health charity sector will have an opportunity to review the proposals for change from the task and finish groups during this consultation.</p><p>NICE also held a webinar with stakeholders in November 2019 to share how and why health technology evaluation is changing and what it means for patients. The webinar is available on the NICE website at the following link:</p><p><a href="https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation" target="_blank">https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation</a></p><p>NICE staff have also participated in a number of events to engage with the patient community, including the charity sector and about the methods review.</p><p><strong> </strong></p>
unstar this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property grouped question UIN 11445 more like this
star this property question first answered
less than 2020-02-06T17:21:30.533Zmore like thismore than 2020-02-06T17:21:30.533Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
394
star this property label Biography information for Mr Clive Betts more like this